Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Nurix Therapeutics Inc (NASDAQ: NRIX) closed the day trading at $9.50 down -1.45% from the previous closing price of $9.64. In other words, the price has decreased by -$1.45 from its previous closing price. On the day, 0.58 million shares were traded.
Ratios:
For a better understanding of NRIX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.26 and its Current Ratio is at 6.26. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 17, 2025, initiated with a Market Perform rating and assigned the stock a target price of $16.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.BMO Capital Markets initiated its Outperform rating on December 06, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when van Houte Hans sold 6,198 shares for $11.33 per share. The transaction valued at 70,243 led to the insider holds 33,724 shares of the business.
JOHANNES VAN HOUTE bought 6,198 shares of NRIX for $69,170 on May 02 ’25. On Apr 30 ’25, another insider, Hansen Gwenn, who serves as the Chief Scientific Officer of the company, sold 3,377 shares for $11.50 each. As a result, the insider received 38,841 and left with 61,516 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 12.84 while its Price-to-Book (P/B) ratio in mrq is 1.51.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $8.18. The 50-Day Moving Average of the stock is -19.40%, while the 200-Day Moving Average is calculated to be -50.92%.
Shares Statistics:
A total of 76.23M shares are outstanding, with a floating share count of 74.72M. Insiders hold about 1.99% of the company’s shares, while institutions hold 108.03% stake in the company.
